title: Effects of telmisartan on C-reactive protein levels: a meta-analysis of randomized controlled trials.
authors.forename: Hisato
authors.initials: H
authors.lastname: Takagi
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Kotaro
authors.initials: K
authors.lastname: Iwata
authors.forename: Shin-nosuke
authors.initials: SN
authors.lastname: Goto
authors.forename: Takuya
authors.initials: T
authors.lastname: Umemoto
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D000077333:Telmisartan; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D001562:Benzimidazoles; D001565:Benzoates; D015415:Biomarkers; D002097:C-Reactive Protein; D000077333:Telmisartan